欢迎访问《临床药物治疗杂志》官方网站,今天是
首个高选择性补体5a受体抑制剂—阿伐可泮
张闪闪, 赵紫楠, 徐文峰, 赵飞, 张天齐, 金鹏飞
A First-in-class highly selective complement 5a receptor antagonist—avacopan
Shanshan ZHANG, Zinan ZHAO, Wenfeng XU, Fei ZHAO, Tianqi ZHANG, Pengfei JIN
临床药物治疗杂志 . 2024, (11): 31 -36 .  DOI: 10.3969/j.issn.1672-3384.2024.11.006